$EXFY
Expensify Inc Stock $exfy

$exfy Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000147684023000187 Filed on November 09, 2023

Income Statement

Concept	2023 Q3
Revenue	$36.49M
YoY Change	-14.12%
Cost Of Revenue	$17.68M
YoY Change	6.8%
Gross Profit	$18.81M
YoY Change	-27.47%
Gross Profit Margin	51.55%
Selling, General & Admin	$27.11M
YoY Change	-4.02%
% of Gross Profit	144.07%
Research & Development	$6.607M
YoY Change	93.41%
% of Gross Profit	35.12%
Depreciation & Amortization	$200.0K
YoY Change	-60.0%
% of Gross Profit	1.06%
Operating Expenses	$33.71M
YoY Change	6.49%
Operating Profit	-$14.90M
YoY Change	160.59%
Interest Expense	-$2.375M
YoY Change	0.25%
% of Operating Profit
Other Income/Expense, Net	-$2.375M
YoY Change
Pretax Income	-$17.27M
YoY Change	113.62%
Income Tax	-$300.0K
% Of Pretax Income
Net Earnings	-$17.00M
YoY Change	106.3%
Net Earnings / Revenue	-46.59%
Basic Earnings Per Share	-$0.21
Diluted Earnings Per Share	-$0.21
COMMON SHARES
Basic Shares Outstanding	82.47M shares
Diluted Shares Outstanding	82.47M shares

Balance Sheet

Concept	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.80M
YoY Change	-12.98%
Cash & Equivalents	$89.12M
Short-Term Investments
Other Short-Term Assets	$27.93M
YoY Change	31.47%
Inventory
Prepaid Expenses	$5.153M
Receivables	$14.51M
Other Receivables	$4.200M
Total Short-Term Assets	$179.6M
YoY Change	-4.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.60M
YoY Change	-1.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$789.0K
YoY Change	36.03%
Total Long-Term Assets	$32.67M
YoY Change	42.65%
TOTAL ASSETS
Total Short-Term Assets	$179.6M
Total Long-Term Assets	$32.67M
Total Assets	$212.3M
YoY Change	0.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.292M
YoY Change	-40.65%
Accrued Expenses	$155.0K
YoY Change	-22.89%
Deferred Revenue	$633.0K
YoY Change	134.44%
Short-Term Debt	$15.00M
YoY Change	0.0%
Long-Term Debt Due	$8.099M
YoY Change	1375.23%
Total Short-Term Liabilities	$73.77M
YoY Change	16.79%
LONG-TERM LIABILITIES
Long-Term Debt	$35.58M
YoY Change	-31.01%
Other Long-Term Liabilities	$1.408M
YoY Change	22.97%
Total Long-Term Liabilities	$36.99M
YoY Change	-29.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.77M
Total Long-Term Liabilities	$36.99M
Total Liabilities	$117.3M
YoY Change	1.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$133.6M
YoY Change	49.21%
Common Stock	$7.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$95.06M
YoY Change
Total Liabilities & Shareholders Equity	$212.3M
YoY Change	0.29%

Cashflow Statement

Concept	2023 Q3
OPERATING ACTIVITIES
Net Income	-$17.00M
YoY Change	106.3%
Depreciation, Depletion And Amortization	$200.0K
YoY Change	-60.0%
Cash From Operating Activities	-$5.110M
YoY Change	450.05%
INVESTING ACTIVITIES
Capital Expenditures	$2.310M
YoY Change	-462.07%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.310M
YoY Change	262.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	670.0K
YoY Change	-121.63%
NET CHANGE
Cash From Operating Activities	-5.110M
Cash From Investing Activities	-2.310M
Cash From Financing Activities	670.0K
Net Change In Cash	-6.750M
YoY Change	44.69%
FREE CASH FLOW
Cash From Operating Activities	-$5.110M
Capital Expenditures	$2.310M
Free Cash Flow	-$7.420M
YoY Change	2449.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	35579000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	51434000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	117258000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	113000000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	7000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	126026000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	50380000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	46564000	usd
	us-gaap	Gross Profit GrossProfit	65099000	usd
	us-gaap	Gross Profit GrossProfit	79462000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17119000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10701000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38386000	usd
	us-gaap	Operating Expenses OperatingExpenses	92262000	usd
	us-gaap	Operating Expenses OperatingExpenses	93994000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27163000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2375000	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2369000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3854000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-23612000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23612000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82085508	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82085508	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80523557	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80523557	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	99863000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	91000	usd
CY2023Q3	exfy	Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions	182000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	30000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1056000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M7D
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	228618000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	194807000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133569000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97573000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	95056000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97241000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	212314000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	210241000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	115479000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45335000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	36757000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	37958000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8242000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8242000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34252000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82469190	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82469190	shares
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	242000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11087000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17003000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	95056000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	92691000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	181000	usd
CY2022Q3	exfy	Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions	247000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	30000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1235000	usd
CY2022Q3	exfy	Stock Issued During Period Value Restricted Stock Award Units Vesting StockIssuedDuringPeriodValueRestrictedStockAwardUnitsVesting	1000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4162000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13839000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8242000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	95815000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	97241000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	216000	usd
	exfy	Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions	584000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	91000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21000	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	3132000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1766000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32831000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-34252000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	95056000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	76615000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	615000	usd
	exfy	Adjustments To Additional Paid In Capital Value Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalValueVestingOfEarlyExercisedStockOptions	998000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	76000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	25000	usd
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	2433000	usd
	exfy	Stock Issued During Period Value Restricted Stock Award Units Vesting StockIssuedDuringPeriodValueRestrictedStockAwardUnitsVesting	1000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4172000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42886000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	95815000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-34252000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23612000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3871000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4072000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	476000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	531000	usd
	exfy	Gain Loss On Impairment Receivables And Sale Or Disposal Of Equipment GainLossOnImpairmentReceivablesAndSaleOrDisposalOfEquipment	-585000	usd
	exfy	Gain Loss On Impairment Receivables And Sale Or Disposal Of Equipment GainLossOnImpairmentReceivablesAndSaleOrDisposalOfEquipment	-722000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30612000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	41793000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	139000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	22000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-86000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	170000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1671000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1016000	usd
	exfy	Increase Decrease In Settlement Assets IncreaseDecreaseInSettlementAssets	9381000	usd
	exfy	Increase Decrease In Settlement Assets IncreaseDecreaseInSettlementAssets	10096000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3672000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1738000	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-14000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1861000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-558000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	125000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-11000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	229000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1575000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4259000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2195000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-236000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-601000	usd
	exfy	Increase Decrease In Settlement Liabilities IncreaseDecreaseInSettlementLiabilities	2451000	usd
	exfy	Increase Decrease In Settlement Liabilities IncreaseDecreaseInSettlementLiabilities	14703000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	78000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	990000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2102000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26229000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1103000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	467000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3730000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	906000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4833000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1373000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	482000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	593000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8450000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	445000	usd
	exfy	Payments For The Repurchases Of Early Exercised Stock Options PaymentsForTheRepurchasesOfEarlyExercisedStockOptions	21000	usd
	exfy	Payments For The Repurchases Of Early Exercised Stock Options PaymentsForTheRepurchasesOfEarlyExercisedStockOptions	25000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3132000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2433000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	216000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	700000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1766000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4172000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10371000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2102000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13102000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22754000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	147710000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125315000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	134608000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148069000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4396000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2721000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3104000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	879000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2219000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1093000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6402000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q3	exfy	Restricted Cash Included In Settlement Assets RestrictedCashIncludedInSettlementAssets	22092000	usd
CY2022Q3	exfy	Restricted Cash Included In Settlement Assets RestrictedCashIncludedInSettlementAssets	25602000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	134608000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148069000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Expensify Neue',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets, income taxes, capitalization of internal-use software costs, stock-based compensation and the Company's incremental borrowing rate utilized to measure its lease right-of-use ("ROU") assets and lease liabilities.</span></div>
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36494000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42493000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	115479000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	126026000	usd
CY2023Q3	exfy	Consideration From Vendors Net ConsiderationFromVendorsNet	2800000	usd
CY2022Q3	exfy	Consideration From Vendors Net ConsiderationFromVendorsNet	1700000	usd
	exfy	Consideration From Vendors Net ConsiderationFromVendorsNet	7300000	usd
	exfy	Consideration From Vendors Net ConsiderationFromVendorsNet	4400000	usd
CY2023Q3	exfy	Card Collateral For Funds Held For Customers Current CardCollateralForFundsHeldForCustomersCurrent	10731000	usd
CY2022Q4	exfy	Card Collateral For Funds Held For Customers Current CardCollateralForFundsHeldForCustomersCurrent	11509000	usd
CY2023Q3	exfy	Employee Stock Purchase Plan Escrow And Other Restricted Cash EmployeeStockPurchasePlanEscrowAndOtherRestrictedCash	101000	usd
CY2022Q4	exfy	Employee Stock Purchase Plan Escrow And Other Restricted Cash EmployeeStockPurchasePlanEscrowAndOtherRestrictedCash	52000	usd
CY2023Q3	exfy	Deferred Contract Acquisition Costs DeferredContractAcquisitionCosts	85000	usd
CY2022Q4	exfy	Deferred Contract Acquisition Costs DeferredContractAcquisitionCosts	0	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	210000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	204000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	27934000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	22217000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	19520000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	14052000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	9273000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	7171000	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	10247000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6881000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2300000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23237000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22019000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8639000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7527000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14598000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14492000	usd
	us-gaap	Depreciation Depreciation	1100000	usd
	us-gaap	Depreciation Depreciation	1500000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	4479000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2721000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2380000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1473000	usd
CY2023Q3	exfy	Accrued Partner Payouts And Advertising Fees Current AccruedPartnerPayoutsAndAdvertisingFeesCurrent	1967000	usd
CY2022Q4	exfy	Accrued Partner Payouts And Advertising Fees Current AccruedPartnerPayoutsAndAdvertisingFeesCurrent	669000	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1328000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1318000	usd
CY2023Q3	exfy	Restricted Common Stock Liability For Early Stock Option Exercises Current RestrictedCommonStockLiabilityForEarlyStockOptionExercisesCurrent	700000	usd
CY2022Q4	exfy	Restricted Common Stock Liability For Early Stock Option Exercises Current RestrictedCommonStockLiabilityForEarlyStockOptionExercisesCurrent	1283000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	633000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	223000	usd
CY2023Q3	exfy	Employee Stock Purchase Plan Payroll Liability EmployeeStockPurchasePlanPayrollLiability	173000	usd
CY2022Q4	exfy	Employee Stock Purchase Plan Payroll Liability EmployeeStockPurchasePlanPayrollLiability	195000	usd
CY2023Q3	exfy	Accrued Credit Card Processing Fees Current AccruedCreditCardProcessingFeesCurrent	40000	usd
CY2022Q4	exfy	Accrued Credit Card Processing Fees Current AccruedCreditCardProcessingFeesCurrent	22000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	100000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	300000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	150000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8234000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1238000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	34188000	usd
CY2023Q3	exfy	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	0	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	43810000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	132000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	8099000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	35579000	usd
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	25204250	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	33.88
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	32.74
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	40.95
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	32.61
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6301650	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.67
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	199898	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	110097	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.76
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5991655	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.67
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5893175	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1200000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10300000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13200000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	46000000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	200000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	700000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11087000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13364000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32831000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	41793000	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	10267000	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	13364000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	30612000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	41793000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.016
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.019
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1900000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3900000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.060
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.195
CY2023Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1300000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1200000	usd
	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17003000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17003000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8242000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8242000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34252000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34252000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23612000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-23612000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82469190	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82469190	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80941664	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80941664	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82085508	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82085508	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80523557	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80523557	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4166678	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5221652	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4673936	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5952390	shares

Files In Submission

Name	View Source	Status
0001476840-23-000187-index-headers.html	Edgar Link	pending
0001476840-23-000187-index.html	Edgar Link	pending
0001476840-23-000187.txt	Edgar Link	pending
0001476840-23-000187-xbrl.zip	Edgar Link	pending
exfy-20230930.htm	Edgar Link	pending
exfy-20230930.xsd	Edgar Link	pending
exhibit311-10xqq32023.htm	Edgar Link	pending
exhibit312-10xqq32023.htm	Edgar Link	pending
exhibit321-10xqq32023.htm	Edgar Link	pending
exhibit322-10xqq32023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
exfy-20230930_cal.xml	Edgar Link	unprocessable
exfy-20230930_def.xml	Edgar Link	unprocessable
exfy-20230930_lab.xml	Edgar Link	unprocessable
exfy-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
exfy-20230930_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXFY
Expensify Inc Stock $exfy

2023 Q3 Form 10-Q Financial Statement

#000147684023000187 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXFY Expensify Inc Stock $exfy

2023 Q3 Form 10-Q Financial Statement

#000147684023000187 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXFY
Expensify Inc Stock $exfy